In the September 9, 2015, Federal Register, FDA
published its determination that Glucagon (glucagon hydrochloride)
for injection, equivalent to (EQ) 1 milligram (mg) base/vial and EQ
10 mg base/vial, was not withdrawn from sale for reasons of safety
or effectiveness. This determination will allow FDA to approve
abbreviated new drug applications for glucagon hydrochloride for
injection, EQ 1 mg base/vial and EQ 10 mg base/vial, if all other
legal and regulatory requirements are met.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.